Latest Food and Drug Administration Stories
http://www.DrugRisks.com is the most helpful resource on the web for prescription medication alerts, side effects and legal news. Visit us today New York, NY (PRWEB) May 03, 2013 The IUD safety advocates at DrugRisks.com are announcing updated information on the site for women using the IUD contraceptive Mirena. Health experts have warned of perforation injuries from the devices as some have already filed legal claims**. DrugRisks was created to provide those using popular medication...
Game Plan Nutrition develops new formula based on safe-for-testing ingredients. Boston, MA (PRWEB) May 03, 2013 Game Plan Nutrition INC (GPLH), a nutritional supplement company slated to launch in the summer of 2013, has developed a revolutionary product formulation that is highly effective and safe for training. Game Plan Nutrition, which will use its proprietary formula in all of its products, will be a line of supplements that enhance the body’s ability to absorb nutrients and...
EyeKor, LLC, a new service provider dedicated to the support of ocular clinical trials, announces FDA 510k clearance of its EXCELSIOR™ image management software as a class 2 medical device, with indications for use specifically for managing ophthalmic clinical trial data. DAVIS, CA and MADISON, WI (PRWEB) May 03, 2013 EyeKor, LLC, a new service provider dedicated to the support of ocular clinical trials, announces FDA 510k clearance of its EXCELSIOR™ image management software as a...
Federal regulators' announcement comes days after Monster Energy sued to halt Dennis Herrera's probe into marketing of potentially unsafe products to children SAN FRANCISCO, May 3, 2013 /PRNewswire/ -- The U.S. Food and Drug Administration earlier today announced that it has launched a formal investigation into the safety of added caffeine in food products--noting "particularly its effects on children and adolescents"--in response to an unfortunate growing trend in which beverage and food...
LYNBROOK, N.Y., May 3, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX(®) in the U.S., announced today that it will host a conference call and live audio webcast at 8:30 a.m. EDT on Friday, May 10, 2013 to report its first quarter 2013 financial results and provide a corporate update. In order to participate in the conference call, please dial 1-800-860-2442...
NEW YORK, May 3, 2013 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Delcath Systems, Inc. ("Delcath" or the "Company") (NasdaqCM: DCTH). The investigation focuses on whether the Company and its executives violated federal securities laws. On May 2, 2013, shares of the Company plunged in after hour trading after an FDA Advisory Committee voted 16-0 against recommending the...
NEW YORK, May 3, 2013 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Aveo Pharmaceuticals, Inc. ("Aveo" or the "Company") (NasdaqGS: Aveo). The investigation focuses on whether the Company and its executives violated federal securities laws. On May 2, 2013, shares of Aveo Pharmaceuticals plunged almost 50 percent after the company said a Food and Drug Administration ("FDA")...
http://www.DrugRisks.com is the most useful source on the web for prescription medication alerts, side effects and legal news. Visit us today Chicago, IL (PRWEB) May 02, 2013 The medication resource center DrugRisks.com is announcing new information on the site for patients taking the blood thinner Pradaxa. A federal judge has ordered drug maker Boehringer Ingelheim to disclose employee reviews and bonuses related to the blood thinner Pradaxa****. DrugRisks was created to improve the...
The DrugRisk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) May 02, 2013 The diabetes drug safety advocates at DrugRisk.com are announcing new information on the site for patients who have taken the diabetes medication Actos. A jury in the first Actos trial last week decided that the maker of the drug didn’t properly warn patients of bladder cancer risks****. The...
Addition of senior executive reflects the company's growth SAN FRANCISCO, May 2, 2013 /PRNewswire/ -- Today, Validant, a leading Quality and Regulatory services firm to global biotechnology, pharmaceutical, and medical device companies, named Michael Beatrice, PhD, as company President. In this role, Mike will assume oversight of all existing client operations and lead the design and development of future service offerings. "Mike will draw from his broad experience and strong...
Latest Food and Drug Administration Reference Libraries
The Chilean sea bass is the North American name for the Patagonian toothfish. The Chilean sea bass name derived in 1977 from Lee Lantz, a fish wholesaler looking for a more attractive name for the American fish market. In 1994 the Food and Drug Administration (FDA) accepted the Chilean sea bass as an alternative name for the Patagonian toothfish. This species is native to the southern Pacific, Atlantic, and Indian Oceans, around seamounts and continental shelves in the colder waters. The...
